Patents by Inventor Ulrike Schaefer

Ulrike Schaefer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190374660
    Abstract: The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. Thus, the present invention concerns compounds that are represented by the general Formulae (Ia) or (Ib).
    Type: Application
    Filed: August 26, 2019
    Publication date: December 12, 2019
    Inventors: Matthias EDER, Klaus KOPKA, Martin SCHÄFER, Ulrike BAUDER-WÜST, Uwe HABERKORN, Michael EISENHUT, Walter MIER, Martina BENESOVA
  • Publication number: 20190365931
    Abstract: The present invention relates to a compound or a pharmaceutically acceptable salt thereof having a chemical structure comprising: (A) at least one motif specifically binding to cell membranes of neoplastic cells; (B) at least one chelator moiety of radiometals; and (C) at least one dye moiety; wherein said compound has a molecular weight of not more than 5 kDa. Further, the invention refers to a method for producing such compound and to the in vivo and in vitro uses thereof.
    Type: Application
    Filed: July 25, 2019
    Publication date: December 5, 2019
    Applicant: DEUTSCHES KREBSFORSCHUNGSZENTRUM
    Inventors: Matthias Eder, Klaus Kopka, Martin Schaefer, Ulrike Bauder-Wuest, Uwe Haberkorn
  • Patent number: 10471160
    Abstract: The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. Thus, the present invention concerns compounds that are represented by the general Formulae (Ia) or (Ib).
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: November 12, 2019
    Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRUM, RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
    Inventors: Matthias Eder, Klaus Kopka, Martin Schäfer, Ulrike Bauder-Wüst, Uwe Haberkorn, Michael Eisenhut, Walter Mier, Martina Benesova, Hans-Christian Kliem, Clemens Kratochwil
  • Publication number: 20190336622
    Abstract: The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. Thus, the present invention concerns compounds that are represented by the general Formulae (Ia) or (Ib).
    Type: Application
    Filed: July 12, 2019
    Publication date: November 7, 2019
    Inventors: Matthias EDER, Klaus KOPKA, Martin SCHÄFER, Ulrike BAUDER-WÜST, Uwe HABERKORN, Michael EISENHUT, Walter MIER, Martina BENESOVA
  • Patent number: 10406246
    Abstract: The present invention relates to a compound or a pharmaceutically acceptable salt thereof having a chemical structure comprising: (A) at least one motif specifically binding to cell membranes of neoplastic cells; (B) at least one chelator moiety of radiometals; and (C) at least one dye moiety; wherein said compound has a molecular weight of not more than 5 kDa. Further, the invention refers to a method for producing such compound and to the in vivo and in vitro uses thereof.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: September 10, 2019
    Assignee: Deutsches Kresbsforschungszentrum
    Inventors: Matthias Eder, Klaus Kopka, Martin Schaefer, Ulrike Bauder-Wuest, Uwe Haberkorn
  • Patent number: 10398791
    Abstract: The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. Thus, the present invention concerns compounds that are represented by the general Formulae (Ia) or (Ib).
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: September 3, 2019
    Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRUM, RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
    Inventors: Matthias Eder, Klaus Kopka, Martin Schäfer, Ulrike Bauder-Wüst, Uwe Haberkorn, Michael Eisenhut, Walter Mier, Martina Benesova
  • Patent number: 10023165
    Abstract: A method for operating a brake system of a vehicle, in particular a motor vehicle, including at least one wheel brake having a displaceable brake piston and an electric motor first actuator of a parking brake and a hydraulic second actuator of an operating brake for displacing the brake piston in each case. For operating the parking brake, the electric motor first actuator is activated in order to set a specifiable target clamping force of the wheel brake. If the maximum clamping force that is achievable by the electric motor first actuator is lower than the target clamping force, then the hydraulic second actuator is activated to provide an additional clamping force.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: July 17, 2018
    Assignee: Robert Bosch GmbH
    Inventors: Frank Baehrle-Miller, Lars Roters, Ulrike Schaefer
  • Publication number: 20160290425
    Abstract: A method for operating a brake system of a vehicle, in particular a motor vehicle, including at least one wheel brake having a displaceable brake piston and an electric motor first actuator of a parking brake and a hydraulic second actuator of an operating brake for displacing the brake piston in each case. For operating the parking brake, the electric motor first actuator is activated in order to set a specifiable target clamping force of the wheel brake. If the maximum clamping force that is achievable by the electric motor first actuator is lower than the target clamping force, then the hydraulic second actuator is activated to provide an additional clamping force.
    Type: Application
    Filed: March 30, 2016
    Publication date: October 6, 2016
    Inventors: Frank Baehrle-Miller, Lars Roters, Ulrike Schaefer
  • Publication number: 20100088781
    Abstract: A method for altering the level of one or more carotenoids in a plant or a tissue within the plant is provided. Method comprises introducing a nucleic acid sequence comprising a regulatory region operatively associated with a silencing nucleotide sequence that reduces or eliminates the expression of a lycopene epsilon cyclase into the plant, and expressing the silencing nucleotide sequence. Expression of the sequence reduces the level of the lycopene epsilon cyclase in the plant or within a tissue of the plant, and results in altering one or more carotenoids.
    Type: Application
    Filed: February 21, 2008
    Publication date: April 8, 2010
    Applicant: HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRE SENTED BY THE MINISTER OF AGRICULTURE AND AGRIFOO
    Inventors: Abdelali Hannoufa, Derek J. Lydiate, Bianyun Yu, Ulrike A. Schäfer